SCHEMBL31240785

SCHEMBL31240785

Cc1cc(-c2cc3c(Cl)ccnc3[nH]2)cc(F)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK9 P50750 3/20 0.47
▸ CDC7 O00311 1/20 0.47
▸ PIM1 P11309 1/20 0.47
▸ EGFR P00533 2/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ AXL P30530 1/20 0.36
▸ PRKCI P41743 1/20 0.36
▸ KIT P10721 1/20 0.35
▸ RIPK1 Q13546 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CCNT1 O60563 2/20 0.35
▸ CCNB2 O95067 3/20 0.35
▸ CDK1 P06493 3/20 0.35
▸ CCNB1 P14635 3/20 0.35
▸ CCNB3 Q8WWL7 3/20 0.35
▸ GSK3A P49840 2/20 0.35
▸ GSK3B P49841 2/20 0.35
▸ CDK5 Q00535 2/20 0.35
▸ CDK5R1 Q15078 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31240691 0.90 CDK9 (0.52) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240630 0.82 CDC7 (0.52) CDK9CDC7PIM1AXLPRKCI
SCHEMBL31240799 0.80 CDK9 (0.42) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240636 0.76 CDK9 (0.40) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240664 0.75 CDK9 (0.48) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240595 0.74 CDK1 (0.49) CDK9CDC7PIM1MAPK14RIPK1
SCHEMBL16041244 0.74 CDC7 (0.59) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240848 0.74 CDC7 (0.59) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240593 0.74 CDC7 (0.59) CDK9CDC7PIM1EGFRMAPK14
SCHEMBL31240779 0.74 CDK9 (0.47) CDK9CDC7PIM1AXLPRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
Send feedback